These results demonstrate that NAT10 stabilizes ETS2 mRNA by catalyzing ac4C acetylation, thereby regulating PD-L1 expression and contributing to the immunosuppressive microenvironment of pancreatic cancer. The gene discussed is NAT10; the disease is pancreatic neoplasm.